LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) will release first quarter 2026 financial results on Tuesday, May 5, 2026 after the market close and will host a conference call at 5:00 PM EDT the same day. Access is by registration for dial-in and PIN; an audio webcast and replay will be available at the company investor site.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
On the day this news was published, LMAT declined 2.20%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 11 | Earnings date notice | Neutral | -0.2% | Set timing and access details for Q4 2025 earnings release and call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date news saw minimal share price reaction.
This announcement schedules LeMaitre’s Q1 2026 earnings release and call, similar to the prior earnings date notice on February 11, 2026 for Q4 2025. That earlier notice coincided with only a -0.23% move, while the subsequent Q4 2025 results on February 25, 2026 brought a much larger reaction. Across recent months, additional news centered on investor conferences and corporate presentations, reinforcing a pattern where timing announcements themselves have modest impact compared with actual earnings releases.
Historical Comparison
Past earnings date news (1 event) saw an average move of -0.23%, suggesting timing notices have typically led to only minor price changes.
Regulatory & Risk Context
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
Contact: Gregory Manker Director, Business Development & Investor Relations LeMaitre Vascular, Inc. +1 781-362-1260 gmanker@lemaitre.com